PyInvesting

Market research

GSKCONS.NSE GlaxoSmithKline Consumer Healthcare Limited

NSE INR Consumer Defensive

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
450B
P/E ratio
38.84
Analyst target
6534
Dividend yield
1.0%
Beta
-0.04

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

GlaxoSmithKline Consumer Healthcare Limited is currently in a long term downtrend where the price is trading 0.0% below its 200 day moving average.

From a valuation standpoint, the stock is 164.4% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 9.1.

Based on the above factors, GlaxoSmithKline Consumer Healthcare Limited gets an overall score of 0/5.